"Blood Test Accurately Detects Cancer in People with Non-Specific Symptoms" https://t.co/VTDIR9GWuv https://t.co/gwJxVsdvfc
RT @NCIEytanRuppin: Metabolomics in blood differentiates both those with cancer and those with and without metastatic disease. Potentially…
RT @NCIEytanRuppin: Metabolomics in blood differentiates both those with cancer and those with and without metastatic disease. Potentially…
Metabolomics in blood differentiates both those with cancer and those with and without metastatic disease. Potentially complementary to circulating tumor DNA detection. https://t.co/Xj3n63WqeW https://t.co/wA1RxTGq2w
RT @RobotRrid: The authors of "Metabolomic Biomarkers in Blood Samples Identify C…" (https://t.co/G8zYXze6Sq) included RRIDs in their paper…
The authors of "Metabolomic Biomarkers in Blood Samples Identify C…" (https://t.co/G8zYXze6Sq) included RRIDs in their paper! RRIDs like this improve reproducibility in scientific research. #methodsmatter #OpenScience
RT @drcadesky: New blood test may accurately detect cancer in people with vague symptoms https://t.co/OHUHyAkYom @MetabolomicsSoc @Philip_…
RT @drcadesky: New blood test may accurately detect cancer in people with vague symptoms https://t.co/OHUHyAkYom @MetabolomicsSoc @Philip_…
New blood test may accurately detect cancer in people with vague symptoms https://t.co/OHUHyAkYom @MetabolomicsSoc @Philip_Edgcumbe @TMIC_Canada
RT @DrAlazri: نوع جديد من اختبار الدم التشخيصي يكشف بدقة السرطان لدى المرضى الذين يعانون من أعراض غير محددة مثل فقدان الوزن غير المبرر والت…
RT @CRUKresearch: Cancer is hard to diagnose in patients who present with non-specific symptoms. #CRUKFunded research from James Larkin + c…
RT @CRUKresearch: Cancer is hard to diagnose in patients who present with non-specific symptoms. #CRUKFunded research from James Larkin + c…
RT @CRUKresearch: Cancer is hard to diagnose in patients who present with non-specific symptoms. #CRUKFunded research from James Larkin + c…
RT @CRUKresearch: Cancer is hard to diagnose in patients who present with non-specific symptoms. #CRUKFunded research from James Larkin + c…
Cancer is hard to diagnose in patients who present with non-specific symptoms. #CRUKFunded research from James Larkin + colleagues @UniOfOxford show that using NMR to examine metabolomic biomarkers in blood samples can identify cancers in these patients: h
Un nouveau test sanguin permet de détecter des cancers sans symptômes spécifiques https://t.co/CjljAQIKKE https://t.co/F7QKc42qE6 https://t.co/19koUqvYlv
Here the paper: Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms Larkin et al https://t.co/cJb707Ht9H
RT @DrPeterBagshaw: Patients with non-specific symptoms where #Cancers are suspected can be difficult to manage This trial shows a potent…
Patients with non-specific symptoms where #Cancers are suspected can be difficult to manage This trial shows a potential blood test may help in deciding who is likely to have cancer Not yet widely available, but an exciting prospect for the future http
RT @V_Bainton: MRI is coupled with an algorithmic model to help detect cancer in patients with non specific symptoms. Here's the full paper…
MRI is coupled with an algorithmic model to help detect cancer in patients with non specific symptoms. Here's the full paper: https://t.co/UVYsA5a0eH #metabolomics #biomarkers #digitalhealth #innovation
RT @LuigiFontana22: Very interesting & promising data: https://t.co/NYziqsYdDy A new metabolomics-based diagnostic blood test can accura…
RT @LuigiFontana22: Very interesting & promising data: https://t.co/NYziqsYdDy A new metabolomics-based diagnostic blood test can accura…
Very interesting & promising data: https://t.co/NYziqsYdDy A new metabolomics-based diagnostic blood test can accurately detect cancer in patients with nonspecific symptoms, such as unexplained weight loss, & differentiating between patients wit
Very interesting and promising results published in CCR: https://t.co/3Sh7AhmL91 A new metabolomics-based diagnostic blood test has been shown to accurately detect cancer in patients with non-specific symptoms, such as unexplained weight loss and fatig…
Interesting Space to watch! https://t.co/YorL8CpDQW
Metobolomica en el presente y futuro cercano de la Medicina de Laboratorio Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms https://t.co/CQkXYY29Zy
In some dope news... https://t.co/k7U0mDTgMm
RT @gometabolic: Fantastic to have this key study published today @CCR_AACR. Exciting news for the future of #cancer #diagnosis https://t.c…
RT @CFrieders: Thrilled to have contributed to this work! Paper available from @CCR_AACR #cancerresearch Metabolomic Biomarkers in Blood…
Excited by this paper from @AACR using #NMR to detect a #metabolic signature identifying #cancer in patients with 'non-specific' symptoms (like feeling bloated/ tired) - from blood samples. The future of cancer diagnosis? https://t.co/9HJYlDPrTl
RT @DrAlazri: نوع جديد من اختبار الدم التشخيصي يكشف بدقة السرطان لدى المرضى الذين يعانون من أعراض غير محددة مثل فقدان الوزن غير المبرر والت…
RT @DrAlazri: نوع جديد من اختبار الدم التشخيصي يكشف بدقة السرطان لدى المرضى الذين يعانون من أعراض غير محددة مثل فقدان الوزن غير المبرر والت…
RT @DrAlazri: نوع جديد من اختبار الدم التشخيصي يكشف بدقة السرطان لدى المرضى الذين يعانون من أعراض غير محددة مثل فقدان الوزن غير المبرر والت…
RT @DrAlazri: نوع جديد من اختبار الدم التشخيصي يكشف بدقة السرطان لدى المرضى الذين يعانون من أعراض غير محددة مثل فقدان الوزن غير المبرر والت…
RT @DrAlazri: نوع جديد من اختبار الدم التشخيصي يكشف بدقة السرطان لدى المرضى الذين يعانون من أعراض غير محددة مثل فقدان الوزن غير المبرر والت…
RT @DrAlazri: نوع جديد من اختبار الدم التشخيصي يكشف بدقة السرطان لدى المرضى الذين يعانون من أعراض غير محددة مثل فقدان الوزن غير المبرر والت…
RT @DrAlazri: نوع جديد من اختبار الدم التشخيصي يكشف بدقة السرطان لدى المرضى الذين يعانون من أعراض غير محددة مثل فقدان الوزن غير المبرر والت…
RT @DrAlazri: نوع جديد من اختبار الدم التشخيصي يكشف بدقة السرطان لدى المرضى الذين يعانون من أعراض غير محددة مثل فقدان الوزن غير المبرر والت…
نوع جديد من اختبار الدم التشخيصي يكشف بدقة السرطان لدى المرضى الذين يعانون من أعراض غير محددة مثل فقدان الوزن غير المبرر والتعب وهذا يجعله أول اختبار للسرطان يعتمد على الدم لتحديد الحالة التشخيص للسرطان دون معرفة مسبقة بنوع السرطان الأولي. https://t.co/H5V
Blood test detects cancer via metabolic biomarkers #bioinnovation #CancerResearch https://t.co/rl3WqpwoGs
New test can identify if a patient has cancer and if it has spread | University of Oxford https://t.co/HtJRkgj9Ip https://t.co/0j9g7SV5Fk
Great work #cancer #diagnosis
#cancerresearch Really interesting paper, well done Fay and team. Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms https://t.co/FbQFPPWRJP
RT @oxomics: Fantastic news: our key study demonstrating the potential for our technology for early #cancer #diagnosis was published this m…
RT @oxomics: Fantastic news: our key study demonstrating the potential for our technology for early #cancer #diagnosis was published this m…
RT @ilyassahinMD: T: 👉Yeni kan testi, "düşük riskli, ancak risksiz olmayan" hasta grubu olarak adlandırılan spesifik olmayan semptomlarla b…
RT @drkpavithran: NMR metabolomics based blood test identifies metastatic cancer with high accuracy https://t.co/y5T1qTYrOj https://t.co/8L…
Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms https://t.co/Tvt7YyYapV
RT @drkpavithran: NMR metabolomics based blood test identifies metastatic cancer with high accuracy https://t.co/y5T1qTYrOj https://t.co/8L…
NMR metabolomics based blood test identifies metastatic cancer with high accuracy https://t.co/y5T1qTYrOj https://t.co/8L8WA5sK1t
Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms https://t.co/obTkXmDW11
T: 👉Yeni kan testi, "düşük riskli, ancak risksiz olmayan" hasta grubu olarak adlandırılan spesifik olmayan semptomlarla birinci basamaktan sevk edilen hastalardaki kanserleri belirleyebilir ve metastatik hastalığı olan ve olmayanları ayırt edebilir. https
👉New blood test can identify cancers in patients referred from primary care with nonspecific symptoms, the so-called “low-risk, but not no-risk” patient group, as well as distinguishing between those with and without metastatic disease. https://t.co/i59dSz
New data from Dr. James Larkin and collaborators from @UniofOxford demonstrating potential of NMR metabolomics #liquidbiopsy in #cancer #diagnostics https://t.co/KI5GOFAyCH
Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms https://t.co/xJgyuLK8dx PDF available
Here's the paper https://t.co/oyeaOywyot
RT @gometabolic: Fantastic to have this key study published today @CCR_AACR. Exciting news for the future of #cancer #diagnosis https://t.c…
RT @oxomics: Fantastic news: our key study demonstrating the potential for our technology for early #cancer #diagnosis was published this m…
Fantastic news: our key study demonstrating the potential for our technology for early #cancer #diagnosis was published this morning @CCR_AACR https://t.co/REd4oxFJyq
Fantastic to have this key study published today @CCR_AACR. Exciting news for the future of #cancer #diagnosis https://t.co/2zJPsUdzSL
Thrilled to have contributed to this work! Paper available from @CCR_AACR #cancerresearch Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms https://t.co/A08sCfMZK5
Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms https://t.co/8YtFlTYk6Q